Researchers say an artificial intelligence program showed promise in predicting ulcerative colitis flare-ups. They say the AI tool could produce test results more quickly and be more cost-effective.

1Lichtenstein GR, et al. Efficacy And Safety Of Guselkumab For Ulcerative Colitis Through Week 92 Of The Quasar Long-Term Extension Study. Poster presentation (#4241842) at Digestive Disease Week ...

Artificial intelligence (AI) is used in ulcerative colitis to assist in the assessment, monitoring, and management of disease. To explain how this technology is being applied in the clinical ...

DOI: 10.1016/j.gie.2023.12.035 Ulcerative colitis (UC) is a chronic colitis of indeterminate origin, characterized by continuous inflammation spreading from the rectum.

All ulcerative colitis patients treated with remestemcel-L had improved clinical and endoscopy scores within two weeks, as defined by the Mayo clinical score and Mayo endoscopic severity (MES ...

Salt Lake City-based Intermountain Health has opened its first freestanding endoscopy center at Alta View Hospital in Sandy, Utah, with two more planned near Riverton Hospital and McKay-Dee Hospital, ...

Mirikizumab, a drug currently approved by the Food and Drug Administration (FDA) for the treatment of ulcerative colitis, also sends Crohn's disease into clinical remission, new findings suggest.

Mesalamine is a medicine for ulcerative colitis (UC) and other types of inflammatory bowel disease (IBD). It belongs to a group of anti-inflammatory medicines called aminosalicylates or 5 ...

TREMFYA® (guselkumab) delivers sustained clinical and endoscopic remission in ulcerative colitis through two years Provided by PR Newswire May 5, 2025, 12:05:00 PM ...